Cargando…
Vasculitis: From Target Molecules to Novel Therapeutic Approaches
Systemic vasculitis is a group of diverse diseases characterized by immune-mediated inflammation of blood vessels. Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are associated with significant side effects. In addition, the management of both small and large vesse...
Autor principal: | Chung, Sang-Wan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301353/ https://www.ncbi.nlm.nih.gov/pubmed/34209028 http://dx.doi.org/10.3390/biomedicines9070757 |
Ejemplares similares
-
New Insights Into Novel Therapeutic Targets in ANCA-Associated Vasculitis
por: Nozaki, Yuji
Publicado: (2021) -
Therapeutic advances in the treatment of vasculitis
por: Eleftheriou, Despina, et al.
Publicado: (2016) -
Lipid A as a Drug Target and Therapeutic Molecule
por: Joo, Sang Hoon
Publicado: (2015) -
Extracellular neutrophil traps: a novel therapeutic target in ANCA-associated vasculitis?
por: Diamantopoulos, Andreas P.
Publicado: (2013) -
Novel Gels: An Emerging Approach for Delivering of Therapeutic Molecules and Recent Trends
por: Sastri, Trideva K., et al.
Publicado: (2022)